X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (37) 37
female (30) 30
oncology (30) 30
aged (29) 29
middle aged (28) 28
index medicus (20) 20
adult (19) 19
antineoplastic combined chemotherapy protocols - therapeutic use (19) 19
cancer (19) 19
chemotherapy (19) 19
male (16) 16
disease-free survival (15) 15
prognosis (14) 14
aged, 80 and over (13) 13
breast neoplasms - drug therapy (13) 13
treatment outcome (12) 12
life sciences (11) 11
breast neoplasms - pathology (10) 10
colorectal cancer (10) 10
antineoplastic combined chemotherapy protocols - adverse effects (9) 9
breast cancer (9) 9
trial (9) 9
chemotherapy, adjuvant (8) 8
colorectal neoplasms - drug therapy (8) 8
analysis (7) 7
care and treatment (7) 7
colorectal neoplasms - pathology (7) 7
deoxycytidine - analogs & derivatives (7) 7
fluorouracil (7) 7
metastasis (7) 7
therapy (7) 7
drug administration schedule (6) 6
health aspects (6) 6
hematology, oncology and palliative medicine (6) 6
neoplasm metastasis (6) 6
neoplasm staging (6) 6
oxaliplatin (6) 6
research (6) 6
breast neoplasms - mortality (5) 5
capecitabine (5) 5
deoxycytidine - administration & dosage (5) 5
fluorouracil - administration & dosage (5) 5
follow-up (5) 5
follow-up studies (5) 5
prospective studies (5) 5
recurrence (5) 5
survival rate (5) 5
trastuzumab (5) 5
vinblastine - analogs & derivatives (5) 5
5-fluorouracil (4) 4
antineoplastic agents, phytogenic - therapeutic use (4) 4
breast neoplasms (4) 4
breast neoplasms - metabolism (4) 4
carcinoma (4) 4
drug therapy (4) 4
fluorouracil - therapeutic use (4) 4
kaplan-meier estimate (4) 4
lymphatic metastasis (4) 4
medical prognosis (4) 4
medicine & public health (4) 4
oncology, experimental (4) 4
quality of life (4) 4
survival (4) 4
taxoids - administration & dosage (4) 4
usage (4) 4
vinblastine - adverse effects (4) 4
1st-line treatment (3) 3
[ sdv.can ] life sciences [q-bio]/cancer (3) 3
adjuvant chemotherapy (3) 3
age factors (3) 3
aged patients (3) 3
antimetabolites, antineoplastic - administration & dosage (3) 3
antineoplastic agents - therapeutic use (3) 3
bevacizumab - administration & dosage (3) 3
camptothecin - analogs & derivatives (3) 3
cancer research (3) 3
cancer therapies (3) 3
chemosensitivity and resistance assay (3) 3
colonic neoplasms - drug therapy (3) 3
colorectal neoplasms (3) 3
combination (3) 3
combined modality therapy (3) 3
deoxycytidine - adverse effects (3) 3
deoxycytidine - therapeutic use (3) 3
development and progression (3) 3
disease progression (3) 3
docetaxel (3) 3
dose-response relationship, drug (3) 3
elderly (3) 3
ex vivo model (3) 3
fluorodeoxyglucose f18 (3) 3
fluorouracil - adverse effects (3) 3
fluorouracil - analogs & derivatives (3) 3
individualized tumor response testing (3) 3
infusions, intravenous (3) 3
lymph nodes - pathology (3) 3
methods (3) 3
neoadjuvant chemotherapy (3) 3
neoplasm recurrence, local - pathology (3) 3
neoplasms. tumors. oncology. including cancer and carcinogens (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 8, pp. 741 - 748
Summary Background Since 2005, 12 months of adjuvant trastuzumab has been the standard treatment for patients with HER2-positive early-stage breast cancer.... 
Hematology, Oncology and Palliative Medicine | ONCOLOGY | FOLLOW-UP | CHEMOTHERAPY | Breast Neoplasms - surgery | Predictive Value of Tests | Breast Neoplasms - secondary | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Young Adult | Breast Neoplasms - chemistry | Antibodies, Monoclonal, Humanized - administration & dosage | Neoplasms, Second Primary | Time Factors | Antineoplastic Agents - adverse effects | Aged, 80 and over | Mastectomy | Adult | Female | Chemotherapy, Adjuvant | France | Heart Diseases - chemically induced | Radiotherapy, Adjuvant | Antibodies, Monoclonal, Humanized - adverse effects | Drug Administration Schedule | Early Detection of Cancer | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Proportional Hazards Models | Treatment Outcome | Breast Neoplasms - drug therapy | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Breast Neoplasms - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - mortality | Aged | Infusions, Intravenous | Receptor, ErbB-2 - analysis | Trastuzumab | Antimitotic agents | Care and treatment | Clinical trials | Breast cancer | Product development | Antineoplastic agents | Cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 15, pp. 1493 - 1505
Journal Article
by de Boer, Stephanie M and Powell, Melanie E and Mileshkin, Linda and Katsaros, Dionyssios and Bessette, Paul and Haie-Meder, Christine and Ottevanger, Petronella B and Ledermann, Jonathan A and Khaw, Pearly and Colombo, Alessandro and Fyles, Anthony and Baron, Marie-Helene and Jürgenliemk-Schulz, Ina M and Kitchener, Henry C and Nijman, Hans W and Wilson, Godfrey and Brooks, Susan and Carinelli, Silvestro and Provencher, Diane and Hanzen, Chantal and Lutgens, Ludy C H W and Smit, Vincent T H B M and Singh, Naveena and Do, Viet and D'Amico, Romerai and Nout, Remi A and Feeney, Amanda and Verhoeven-Adema, Karen W and Putter, Hein and Creutzberg, Carien L and McCormack, Mary and Whitmarsh, Karen and Allerton, Rozenn and Gregory, Deborah and Symonds, Paul and Hoskin, Peter J and Adusumalli, Madhavi and Anand, Anjana and Wade, Robert and Stewart, Alexandra and Taylor, Wendy and Kruitwagen, Roy F.P.M and Hollema, Harry and Pras, Elizabeth and Snyers, An and Stalpers, Lukas and Jobsen, Jan J and Slot, Annerie and Mens, Jan-Willem M and Stam, Tanja C and Van Triest, Baukelien and Van der Steen - Banasik, Elzbieta M and De Winter, Karin A.J and Quinn, Michael A and Kolodziej, Ilka and Pyman, Jan and Johnson, Carol and Capp, Anne and Fossati, Roldano and Gribaudo, Sergio and Lissoni, Andrea A and Ferrero, Annamaria and Artioli, Grazia and Davidson, Cathy and McLachlin, C. Meg and Ghatage, Prafull and Rittenberg, Paula V.C and Souhami, Luis and Thomas, Gillian and Duvillard, Pierre and Berton-Rigaud, Dominique and Tubiana-Mathieu, Nicole and PORTEC Study Grp and PORTEC study group
The Lancet Oncology, ISSN 1470-2045, 03/2018, Volume 19, Issue 3, pp. 295 - 309
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 4/2012, Volume 132, Issue 3, pp. 895 - 915
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. e23234 - e23234
Journal Article
Journal Article
BJU International, ISSN 1464-4096, 01/2015, Volume 115, Issue 1, pp. 65 - 73
Journal Article
European Urology, ISSN 0302-2838, 05/2018, Volume 73, Issue 5, pp. 696 - 703
Journal Article